Femasys Inc is trading 10.2% down at $4.72 as investors react to a sharp reset in Wall Street expectations following the company's recent 1-for-20 reverse stock split.
- Analysts have established a new average 12-month price target of $3.23, which sits significantly below the current post-split trading levels.
- The downward revision is weighing on market sentiment and encouraging profit-taking following a period of extreme volatility triggered by the split.